Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
Louise Emmett,Shalini Subramaniam,Megan Crumbaker,Anthony M. Joshua,Shahneen Sandhu,Andrew Nguyen,Andrew Weickhardt,Sze-Ting Lee,Siobhan Ng,Roslyn J. Francis,Jeffrey C. Goh,David A. Pattison,Thean Hsiang Tan,Ian Kirkwood,Craig Gedye,Natalie Rutherford,Aravind S. Ravi Kumar,David Pook,Shakher Ramdave,David Nadebaum
PDF的下载单位、IP信息已删除
(2025-6-4)
蓝天
轨迹
无极微光
典雅的人生
Adc
cnspower
smottom
lizishu
Criminology34
乐空思
快乐滑板
jiaaaaa
lanxinyue
pluto
风吹麦田
核桃
111
zhonglv7
Mic
666
归尘
Singularity
GingerF
eric888
皖公网安备34019202002308
